Bioprogress BPRG - Serious Investors Only (Moderated)

BioProgress (Pharmaceuticals & Biotechnology, Buy) - Product Launch and TabWrap placement

BioProgress today announced that its had launched the reformulated versions of two products acquired with the airPharma acquisition, less than two months following the acquisition. This is even faster than the reformulations and launches following the Dexo acquisition earlier in the year and shows that with the enhanced team, the focused products and the improvements in technology formulation, BioProgress is making fast progress in its move into branded consumer OTC products market. In addition, it announced that it had placed its first TabWrap production system into validity and stability testing with a partner, Inyx. Following successful testing, Inyx, which already has FDA and EMEA approval, will likely be able to start manufacturing for BioProgress' and 3rd party product developments. Having had two years of substantial change, the business is now going into a period of delivery on this new strategy and therefore we are looking for substantial profits growth in 2007. Buy to 88p.

Elizabeth Klein 020 7003 3523 elizabeth.klein@bridgewell.co.uk